Literature DB >> 28330887

Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Naohisa Urabe1, Susumu Sakamoto2, Go Sano1, Junko Suzuki3, Akira Hebisawa4, Yasuhiko Nakamura1, Kazuya Koyama1, Yoshikazu Ishii5, Kazuhiro Tateda5, Sakae Homma1.   

Abstract

We evaluated the usefulness of an Aspergillus galactomannan (GM) test, a β-d-glucan (βDG) test, and two different Aspergillus PCR assays of bronchoalveolar lavage fluid (BALF) samples for the diagnosis of chronic pulmonary aspergillosis (CPA). BALF samples from 30 patients with and 120 patients without CPA were collected. We calculated the sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio for each test individually and in combination with other tests. The optical density index values, as determined by receiver operating characteristic analysis, for the diagnosis of CPA were 0.5 and 100 for GM and βDG testing of BALF, respectively. The sensitivity and specificity of the GM test, βDG test, and PCR assays 1 and 2 were 77.8% and 90.0%, 77.8% and 72.5%, 86.7% and 84.2%, and 66.7% and 94.2%, respectively. A comparison of the PCR assays showed that PCR assay 1 had a better sensitivity, a better negative predictive value, and a better negative likelihood ratio and PCR assay 2 had a better specificity, a better positive predictive value, and a better positive likelihood ratio. The combination of the GM and βDG tests had the highest diagnostic odds ratio. The combination of the GM and βDG tests on BALF was more useful than any single test for diagnosing CPA.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus PCR assays; Aspergillus galactomannan test; chronic pulmonary aspergillosis; β-d-glucan test

Mesh:

Substances:

Year:  2017        PMID: 28330887      PMCID: PMC5442530          DOI: 10.1128/JCM.02497-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors:  C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Françoise Gavini; Huub J M Op den Camp; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.

Authors:  D Buchheidt; C Baust; H Skladny; J Ritter; T Suedhoff; M Baldus; W Seifarth; C Leib-Moesch; R Hehlmann
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

4.  Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.

Authors:  Juliette Camuset; Hilario Nunes; Marie-Christine Dombret; Anne Bergeron; Priscilla Henno; Bruno Philippe; Gaelle Dauriat; Gilles Mangiapan; Antoine Rabbat; Jacques Cadranel
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

5.  A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus.

Authors:  N Golbang; J P Burnie; R C Matthews
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

6.  Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.

Authors:  Shigeru Kohno; Koichi Izumikawa; Kenji Ogawa; Atsuyuki Kurashima; Niro Okimoto; Ryoichi Amitani; Hiroshi Kakeya; Yoshihito Niki; Yoshitsugu Miyazaki
Journal:  J Infect       Date:  2010-08-24       Impact factor: 6.072

7.  Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Authors:  Annie Sulahian; Raphael Porcher; Anne Bergeron; Sophie Touratier; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

8.  Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?

Authors:  Koichi Izumikawa; Takayoshi Tashiro; Masato Tashiro; Takahiro Takazono; Kosuke Kosai; Yoshitomo Morinaga; Shintaro Kurihara; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Misuzu Tsukamoto; Hiroshi Kakeya; Tomayoshi Hayashi; Katsunori Yanagihara; Takeshi Nagayasu; Shigeru Kohno
Journal:  J Infect Chemother       Date:  2013-12-11       Impact factor: 2.211

9.  The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.

Authors:  Yuta Kono; Kenji Tsushima; Koichi Yamaguchi; Nao Kurita; Seiko Soeda; Akahito Fujiwara; Shinya Sugiyama; Yuki Togashi; Satoshi Kasagi; Masako To; Yasuo To; Yasuhiro Setoguchi
Journal:  Respir Med       Date:  2013-04-28       Impact factor: 3.415

10.  Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.

Authors:  Hae-Seong Nam; Kyeongman Jeon; Sang-Won Um; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Won-Jung Koh
Journal:  Int J Infect Dis       Date:  2009-11-11       Impact factor: 3.623

View more
  10 in total

1.  Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Inderpaul Singh Sehgal; Sahajal Dhooria; Hansraj Choudhary; Ashutosh Nath Aggarwal; Mandeep Garg; Arunaloke Chakrabarti; Ritesh Agarwal
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

2.  Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Takahiro Takazono; Yuya Ito; Masato Tashiro; Keitaro Nishimura; Tomomi Saijo; Kazuko Yamamoto; Yoshifumi Imamura; Taiga Miyazaki; Katsunori Yanagihara; Hiroshi Mukae; Koichi Izumikawa
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 3.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 4.  Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis.

Authors:  Takahiro Takazono; Koichi Izumikawa
Journal:  Front Microbiol       Date:  2018-08-17       Impact factor: 5.640

5.  Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis.

Authors:  Elizabeth Stucky Hunter; Malcolm D Richardson; David W Denning
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

Review 6.  Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.

Authors:  Malcolm A Finkelman
Journal:  J Fungi (Basel)       Date:  2020-12-29

7.  ATS Core Curriculum 2020. Adult Pulmonary Medicine.

Authors:  Colleen L Channick; Garth Garrison; Tristan J Huie; Erin Narewski; Caralee Caplan-Shaw; Josalyn Cho; Samaan Rafeq; Raed Alalawi; Rami Alashram; Kristina L Bailey; Eva M Carmona; Naomi Habib; Rebecca Kapolka; Amita Krishnan; Matthew R Lammi; Tyler Peck; Kelly M Pennington; Parth Rali; Bronwyn L Small; Colin Swenson; Alison Witkin; Margaret M Hayes
Journal:  ATS Sch       Date:  2020-10-08

8.  Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.

Authors:  Waqas Akram; Muhammad Bilal Ejaz; Tauqeer Hussain Mallhi; Syed Azhar Bin Syed Sulaiman; Amer Hayat Khan
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

9.  Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Helmut J F Salzer; Juergen Prattes; Holger Flick; Maja Reimann; Jan Heyckendorf; Barbara Kalsdorf; Sabrina Obersteiner; Karoline I Gaede; Christian Herzmann; Gemma L Johnson; Christoph Lange; Martin Hoenigl
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

10.  Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis.

Authors:  Xiuqing Ma; Kaifei Wang; Xin Zhao; Yang Liu; Yanqin Li; Xiaotian Yu; Chunsun Li; David W Denning; Lixin Xie
Journal:  BMC Infect Dis       Date:  2019-08-06       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.